Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;6(1):e70171.
doi: 10.1002/deo2.70171. eCollection 2026 Apr.

Treatment of Hepatocellular Carcinoma Using Endoscopic Ultrasound-guided Radiofrequency Ablation: A Case Series

Affiliations

Treatment of Hepatocellular Carcinoma Using Endoscopic Ultrasound-guided Radiofrequency Ablation: A Case Series

Yogesh Harwani et al. DEN Open. .

Abstract

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is an emerging technique for treating pancreatic and neuroendocrine tumors in patients who are not candidates for surgery. However, there is limited evidence of EUS-RFA in hepatic cancers. The present case series describes five elderly patients with compensated cirrhotic hepatocellular carcinomas (HCCs) treated locally using EUS-RFA. Alpha-fetoprotein levels were reduced in patients after 1 month of the procedure. Computed tomography analysis also reported a reduction in HCCs in patients postoperatively. Repeat computed tomography triple-phase abdomen also showed complete radiological response to treatment in lesions <3 cm. None of the patients reported any procedural adverse event. EUS-RFA offers safe ablation of <3 cm HCC lesions.

Keywords: case series; endoscopic ultrasound; hepatocellular carcinomas; liver cirrhosis; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Diagrammatic representation of the feasibility of liver segments for endoscopic ultrasound‐guided radiofrequency ablation (EUS‐RFA) based on needle positioning.
FIGURE 2
FIGURE 2
Intraoperative linear endoscopic ultrasound (EUS) taken during the radiofrequency ablation (RFA) procedure. (a) Hepatocellular carcinoma (HCC) in segment III of the liver; (b) EUSRA RFA probe within lesion; (c) Echogenic bubbles observed post‐RFA.
FIGURE 3
FIGURE 3
(a) Pre‐ablation hepatocellular carcinoma (HCC) lesion at segment II in case 5; (b) 1‐month post‐ablation HCC lesion at segment II in case 5; (c) Pre‐ablation HCC lesion at segment VI in case 5; (d) 1‐month post‐ablation HCC lesion at segment VI in case 5.

References

    1. Abboud Y., Ismail M., Khan H., et al., “Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades,” Journal of Clinical and Translational Hepatology 12, no. 2 (2024): 172–81, 10.14218/JCTH.2023.00356. - DOI - PMC - PubMed
    1. Tanaka T., Takata K., Miyayama T., et al., “Long‐term Outcome and Eligibility of Radiofrequency Ablation for Hepatocellular Carcinoma Over 3.0 cm in Diameter,” Scientific Reports 13 (2023): 16286, 10.1038/s41598-023-43516-w. - DOI - PMC - PubMed
    1. de Nucci G., Della Corte C., Reati R., Imperatore N., Arena I., and Larghi A., “Endoscopic Ultrasound‐guided Radiofrequency Ablation for Hepatocellular Carcinoma in Cirrhosis: A Case Report Test for Efficacy and Future Perspectives,” Endoscopy International Open 8, no. 11 (2020): E1713–6, 10.1055/a-1236-3105. - DOI - PMC - PubMed
    1. Gollapudi L. A. and Tyberg A., “EUS‐RFA of the Pancreas: Where Are We and Future Directions,” Translational Gastroenterology and Hepatology 7 (2022): 18, 10.21037/tgh-2020-11. - DOI - PMC - PubMed
    1. Rossi G., Petrone M. C., Capurso G., Partelli S., Falconi M., and Arcidiacono P. G., “Endoscopic Ultrasound Radiofrequency Ablation of Pancreatic Insulinoma in Elderly Patients: Three Case Reports,” World Journal of Clinical Cases 10, no. 19 (2022): 6514–9, 10.12998/wjcc.v10.i19.6514. - DOI - PMC - PubMed

LinkOut - more resources